CA2115346A1 - Anticorps chimerique anti-cea - Google Patents
Anticorps chimerique anti-ceaInfo
- Publication number
- CA2115346A1 CA2115346A1 CA002115346A CA2115346A CA2115346A1 CA 2115346 A1 CA2115346 A1 CA 2115346A1 CA 002115346 A CA002115346 A CA 002115346A CA 2115346 A CA2115346 A CA 2115346A CA 2115346 A1 CA2115346 A1 CA 2115346A1
- Authority
- CA
- Canada
- Prior art keywords
- sequence
- seq
- human
- ser
- none
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90407492A | 1992-06-15 | 1992-06-15 | |
US07/904,074 | 1992-06-15 | ||
PCT/US1993/005709 WO1993025237A1 (fr) | 1992-06-15 | 1993-06-15 | Anticorps chimerique anti antigene carcino-embryonnaire |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2115346A1 true CA2115346A1 (fr) | 1993-12-23 |
Family
ID=25418496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002115346A Abandoned CA2115346A1 (fr) | 1992-06-15 | 1993-06-15 | Anticorps chimerique anti-cea |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0606430A1 (fr) |
JP (1) | JPH06509947A (fr) |
AU (1) | AU4536693A (fr) |
CA (1) | CA2115346A1 (fr) |
WO (1) | WO1993025237A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6165793A (en) * | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6309883B1 (en) | 1994-02-17 | 2001-10-30 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US20060257890A1 (en) * | 1996-05-20 | 2006-11-16 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US6153410A (en) * | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
GB9712512D0 (en) | 1997-06-16 | 1997-08-20 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
US6958213B2 (en) | 2000-12-12 | 2005-10-25 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4921690A (en) * | 1986-12-29 | 1990-05-01 | City Of Hope | Method of enhancing the biodistribution of antibody for localization in lesions |
US5081235A (en) * | 1989-07-26 | 1992-01-14 | City Of Hope | Chimeric anti-cea antibody |
-
1993
- 1993-06-15 CA CA002115346A patent/CA2115346A1/fr not_active Abandoned
- 1993-06-15 EP EP93915354A patent/EP0606430A1/fr not_active Withdrawn
- 1993-06-15 JP JP6501788A patent/JPH06509947A/ja active Pending
- 1993-06-15 WO PCT/US1993/005709 patent/WO1993025237A1/fr not_active Application Discontinuation
- 1993-06-15 AU AU45366/93A patent/AU4536693A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPH06509947A (ja) | 1994-11-10 |
EP0606430A1 (fr) | 1994-07-20 |
AU4536693A (en) | 1994-01-04 |
WO1993025237A1 (fr) | 1993-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2070659C (fr) | Preparation d'anticorps | |
US5968509A (en) | Antibodies with binding affinity for the CD3 antigen | |
Neumaier et al. | Cloning of the genes for T84. 66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84. 66 genes in myeloma and Chinese hamster ovary cells | |
AU606320B2 (en) | Modular assembly of antibody genes, antibodies prepared thereby and use | |
US5877293A (en) | CDR grafted anti-CEA antibodies and their production | |
Fell et al. | Homologous recombination in hybridoma cells: heavy chain chimeric antibody produced by gene targeting. | |
AU629401B2 (en) | Chimeric anti-cea antibody | |
AU626254B2 (en) | Chimeric antibody with specificity to human tumor antigen | |
CA2155934A1 (fr) | Nouvelle famille d'anticorps chimeriques diriges contre les antigenes carcinoembryonnaires | |
HU215383B (hu) | Humanizált antitest és eljárás előállítására | |
ZA200100478B (en) | Hybrid human/rodent igg antibody to cd3, and methods of its construction. | |
GB2276169A (en) | Antibodies specific for carcinoembryonic antigen | |
CA2115346A1 (fr) | Anticorps chimerique anti-cea | |
US5075431A (en) | Chimeric anti-CEA antibody | |
US6232123B1 (en) | Monoclonal antibodies against leucocyte-specific G protein-coupled receptors | |
AU652923B2 (en) | Specific binding agents | |
US5674994A (en) | Polynucleotides encoding the anti-PEM antibody BW835 variable domains and expression vectors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |